‘Ηαρ
Jo}[s^Ιζι~INj[μ«ΙDooseΗσQΖff΅GgXNV~hͺψ΅½3Ξj
εϋό@i1, {{@Yτ3, ΄{@Ni1, ΄c@±Ζt1, c@Ψq1, ¬μ@χ’1, μ@1, μγ@NF2, Ec@^1
1ϊ{γΘεw ¬a@¬Θ
2ϊ{γΘεw½iRa@¬Θ
3Ή}AiγΘεw¬Θ
A Case of Doose Syndrome Successfully Treated with Ethosuximide in a 3-Year-Old Boy Diagnosed after Carbamazepine Administration Induced Myoclonic Seizures
Eiji Otaka1, Yusaku Miyamoto3, Koji Hashimoto1, Kotoha Harada1, Hanako Tajima1, Juri Ogawa1, Jun Hayakawa1, Yasuhiko Kawakami2 and Makoto Migita1
1)Department of Pediatrics, Nippon Medical School, Musashi Kosugi Hospital
2)Department of Pediatrics, Nippon Medical School, Tama Nagayama Hospital
3)Department of Pediatrics, St. Marianna University School of Medicine

A 3-year-old boy with a history of four febrile convulsions since the age of 1 year was admitted to the hospital after experiencing a cluster of tonic seizures. Treatment was started with valproic acid (VPA), which proved to be ineffective, so carbamazepine (CBZ) was administered instead. This was judged to be effective because the tonic seizures disappeared temporarily. The patient was discharged, but he then had a similar cluster of tonic seizures and was consequently readmitted. Zonisamide (ZNS) was administered, which resolved the tonic seizures. CBZ was discontinued because we thought it would exacerbate the myoclonic seizures he was experiencing. The myoclonic seizures disappeared, and the addition of ethosuximide (ESM) completely resolved his tonic seizures. In this patient, the onset of tonic seizures was characterized by clusters, but because myoclonic seizures were not prominent initially, we were unable to diagnose Doose syndrome early. However, ESM proved remarkably effective, and the patient has remained seizure free.
ϊγεγο 2023; 19(2), 171-176
Key words
Doose syndrome, myoclonic atonic epilepsy, myoclonic seizure, carbamazepine, ethosuximide
Correspondence to
Eiji Otaka, Department of Pediatrics, Nippon Medical School, Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa 211-8533, Japan
E-mailFe-otaka@nms.ac.jp
σtF2023N130ϊ@σF2023N224ϊ |